In September, a federal court ruled that Stratagene infringed two patents covering Third Wave's Invader technology.
Later that month, the court found Stratagene liable for willful patent infringement and awarded Third Wave $5.3 million in damages. The court also prohibited Stratagene from making, selling, or offering to sell its FullVelocity QPCR and QRT-PCR products.
Third Wave said today that it "sought the additional damages, given the willful infringement verdict."
Kevin Conroy, president and CEO of Third Wave, said in a statement today that the increase in damages "will send a strong signal to others who would infringe Third Wave's unique and valuable intellectual property."
Stratagene officials were not immediately available for comment.